Literature DB >> 27106956

What does it mean to put new hepatitis C drugs on a list of essential medicines?

Julian Urrutia1, Thalia Porteny2, Norman Daniels3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27106956     DOI： 10.1136/bmj.i2035

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Incremental cost and cost-effectiveness of the addition of indoor residual spraying with pirimiphos-methyl in sub-Saharan Africa versus standard malaria control: results of data collection and analysis in the Next Generation Indoor Residual Sprays (NgenIRS) project, an economic-evaluation.

Authors:  Joshua Yukich; Peder Digre; Sara Scates; Luc Boydens; Emmanuel Obi; Nicky Moran; Allison Belemvire; Mariandrea Chamorro; Benjamin Johns; Keziah L Malm; Lena Kolyada; Ignatius Williams; Samuel Asiedu; Seydou Fomba; Jules Mihigo; Desire Boko; Baltazar Candrinho; Rodaly Muthoni; Jimmy Opigo; Catherine Maiteki-Sebuguzi; Damian Rutazaana; Josephat Shililu; Asaph Muhanguzi; Kassahun Belay; Joel Kisubi; Joselyn Annet Atuhairwe; Presley Musonda; Nduka Iwuchukwu; John Ngosa; Elizabeth Chizema; Reuben Zulu; Emmanuel Kooma; John Miller; Adam Bennett; Kyra Arnett; Kenzie Tynuv; Christelle Gogue; Joseph Wagman; Jason H Richardson; Laurence Slutsker; Molly Robertson
Journal:  Malar J       Date:  2022-06-11       Impact factor: 3.469

2.  National List of Essential Medicines in India: A Story of Deprivation of Substance Use Disorder Treatment.

Authors:  Arpit Parmar; Arghya Pal; Pawan Sharma
Journal:  Indian J Psychol Med       Date:  2020-12-07

3.  List of essential psychotherapeutic medicines 2019 of India: When science was left behind.

Authors:  Arpit Parmar; Santanu Nath; Susanta Kumar Padhy
Journal:  Indian J Psychiatry       Date:  2022-03-24       Impact factor: 2.983

4.  When cost-effective interventions are unaffordable: Integrating cost-effectiveness and budget impact in priority setting for global health programs.

Authors:  Alyssa Bilinski; Peter Neumann; Joshua Cohen; Teja Thorat; Katherine McDaniel; Joshua A Salomon
Journal:  PLoS Med       Date:  2017-10-02       Impact factor: 11.069
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.